3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million
Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.
According to Zhiyong Finance APP, Amaero (AMRO.US), a producer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, resumed its initial public offering (IPO) plans in the United States on Thursday. It submitted new documents to the U.S. Securities and Exchange Commission (SEC), disclosing a reduced scale of stock issuance. The company is already listed on the Australian Securities Exchange. Amaero previously attempted a cross-listing on Nasdaq in September, but postponed the plan due to an unfavorable market environment. The exact date of the IPO has yet to be determined.
The company, headquartered in McDonald, Tennessee, now plans to issue 3.9 million shares at an assumed price of $5.15 per share, raising $20 million. This price corresponds to Amaero’s latest share price on the Australian Securities Exchange. Previously, the company had filed to issue 7.5 million shares at $7.06 per share, aiming to raise up to $53 million. Under the revised terms, Amaero’s fundraising will decrease by 62% compared to previous expectations, with the fully diluted market capitalization dropping to $143 million, a 35% decrease from earlier projections.
Amaero mainly produces spherical refractory metal and titanium alloy powders for additive manufacturing and also provides large near-net-shape components made by powder metallurgy hot isostatic pressing processes. Its products cover powder materials such as niobium, tungsten, tantalum, molybdenum, rhenium, and titanium alloys, designed specifically for the 3D printing of critical components in hypersonic weapon systems, satellite propulsion, strategic missiles, aerospace, and medical sectors.
Amaero was founded in 2013. For the twelve months ending June 30, 2026, the company achieved revenue of approximately $12 million. It plans to list on Nasdaq under the ticker “AMRO”. Baird and Lake Street Capital Markets are acting as joint bookrunners for the offering; former lead underwriter Stifel is no longer serving as an underwriter.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Shares of Oxford Metrics in the UK fell as the company forecast a fiscal year loss, while the market had previously generally expected the company to turn a profit.
On October 9th, shares of smart sensing technology company Oxford Metrics OMG1.L fell by 14% to 30 pence, marking their lowest level since March 2015. The company expects an adjusted operating loss of between £500,000 and £3.9 million for fiscal 2026, while the market consensus was for a profit of £3 million. Oxford Metrics noted that key markets served by its motion capture division, Vicon, remain soft, with R&D funding under pressure and major projects in the industrial vision and measurement systems business facing delays. The company has acquired the assets of Move AI to enhance Vicon’s AI-based motion capture technology and reach more customers and markets. Year-to-date, the share price has dropped about 45%, including the decline on the day. (For the convenience of non-English speakers, Reuters has automated translation of its reports into various other languages. As automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides it as a convenience only. Reuters is not responsible for any damage or loss caused by the use of automated translation features.)
BUZZ-European telecom stocks fall after SpaceX reaches spectrum agreement
On Thursday, SpaceX SPCX.O announced it had reached an agreement (link) to acquire a portfolio of low-frequency band spectrum licenses across the United States, which will enable Starlink Mobile to become a major telecommunications operator in the US. Following this news, shares of European telecom service providers fell by 3% to 7%. Deutsche Telekom DTEGn.DE, which holds a 54% stake in T-Mobile US TMUS.O, saw its share price drop by 7%, set for its biggest single-day loss since June 2023. “Deutsche Telekom is negatively impacted as competition in the US market intensifies,” according to a local trader. This acquisition could potentially allow SpaceX to provide direct mobile communication services to smartphones from space in the future. Scotiabank pointed out, “SpaceX’s acquisition of spectrum in the US today makes the threat of hybrid networks more realistic, though network capacity and deployment economics in dense markets have yet to be validated.” Spanish operator Telefonica TEF.MC, France's Orange SA ORAN.PA, and UK’s Vodafone VOD.L all declined by about 3%. The European STOXX 600 telecom index .SXKP dropped 2.8%. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since these automated translations may contain errors or lack the needed context, Reuters does not guarantee the accuracy of automated translation texts and provides them for reader convenience only. Reuters bears no responsibility for any harm or loss due to use of automated translation.)
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Current Spread in Yield Basis Points U.S. 5.243 % Australia 5.345 % 10.2 Belgium 4.295 % -94.8 Canada 3.929 % -131.4 Denmark 3.260 % -198.4 France 4.816 % -42.7 Germany 3.474 % -177.0 Italy 4.540 % -70.3 Japan 3.017 % -222.6 Netherlands 3.577 % -166.6 Spain 4.064 % -117.9 Sweden 3.205 % -203.8 U.K. 5.427 % 18.4 Source: Tullett Prebon via FactSet (END) Dow Jones Newswires October 09, 2026 04:10 ET (08:10 GMT)
TRexBio Prices $116.7 Million Initial Public Offering
04:10 AM EDT, 10/09/2026 (MT Newswires) -- TRexBio (TRXB) said Thursday it priced its initial public offering of roughly 8.3 million common shares at $14 per share. The company expects to raise roughly $116.7 million in gross proceeds from the sale, and its stock is expected to begin trading Friday on the Nasdaq Global Select Market (NDAQ) under the ticker symbol TRXB, the company said. Underwriters have a 30-day option to buy up to an additional 1.25 million shares, and the transaction is expected to close Oct. 13, pending customary conditions, TRexBio said.
Crypto prices
More
